MedicinehospitalEssential

Measles + Rubella Vaccine

A live combined measles, mumps and rubella (MMR) vaccine for people 12 months and older.

Clinical information

Common uses

prevention of measles
prevention of rubella
prevention of mumps

Common side effects

injection-site pain, redness or swelling
fever
measles-like or rubella-like rash

Cautions

not for people with weakened immune systems
not during moderate or severe febrile illness or untreated TB
caution after egg anaphylaxis or febrile seizures
caution with a history of low platelets (thrombocytopenia)

Interactions

immune globulins and blood products — do not give together
can temporarily blunt tuberculin (TB) skin tests

Pregnancy: do not give — avoid pregnancy for 1 month after

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, M-M-R II (measles, mumps, and rubella virus vaccine live) label, setid 0a9e384f-e717-436b-b9a0-15e53cef0862 (accessed 2026-08-16)

Approved brands & formulations4

Brand name	Dosage form	Strength	Importer	Category
Diphtheria Toxoid s 25 Lf (≥ 30 IU) Measles virus 50+mumps virus + Rubella virus	Parenteral ( Vaccine )	1000CCID50 + 5000CCID50+1000CCID50	HPA designated importers	hospital
Measles and Rubella Vaccine (Live) (Attenuated, Freeze Dried)	Parenteral ( Lyophilized Powder for Injection )	CAM-70 strain ≥ 1000 CCID50 Wistar RA 27/3 strain ≥ 1000 CCID50	HPA designated importers	hospital
Measles And Rubella Vaccine ( Mmr Vaccine )	Parenteral ( Live, Attenuated (Freeze-Dried vaccine)	Each single human dose when reconstituted in a volume of 0.5ml contains not less than 1000 CCID50 of measles virus and 1000 CCID50 of rubella virus	—	hospital
Measles + Rubella Vaccine	Parenteral ( Injection )	1000 CCID 50 + 1000 CCID 50 / 0.5ml S/C	—	hospital